immune thrombocytopenia

7 · 20 / page

Ask MedXY AI

Latest news

Tag

$Complement Activation May Define a Refractory Subset of Adult ITP$

Hematology-Oncologybệnh huyết họccomplement activation

Complement Activation May Define a Refractory Subset of Adult ITP

By MedXY|Jun 19, 2026

Complement deposition on platelets identifies a biologically distinct subset of adult ITP associated with higher platelet turnover and more first-line treatment refractoriness.

Hematology-Oncologyimmune thrombocytopeniapediatric hematology

immune thrombocytopenia

Latest news

Complement Activation May Define a Refractory Subset of Adult ITP

New Statistical Model Predicts Chronic ITP in Children at Diagnosis

Iptacopan Demonstrates Clinical Efficacy in Cold Agglutinin Disease While Falling Short in Immune Thrombocytopenia: Results from a Phase 2 Basket Trial

Short-Course Ianalumab Combined with Eltrombopag: A Potential Shift Toward Sustained Remission in Immune Thrombocytopenia

B-Cell Depletion Meets TPO-RA: Ianalumab and Eltrombopag Redefine Treatment Success in Immune Thrombocytopenia

CM313, a Novel Anti-CD38 Monoclonal Antibody, Demonstrates Promising Efficacy and Safety in Persistent or Chronic Primary Immune Thrombocytopenia: Insights from a Phase 2 Randomized Trial

Avatrombopag in Pediatric Immune Thrombocytopenia: Evidence from the AVA-PED-301 Phase 3b Trial